Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Mostrar outras versões (1)

The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a mur...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Poyntz, H, Stylianou, E, Griffiths, K, Marsay, L, Checkley, A, McShane, H
Formato:	Journal article
Publicado em:	2014

Registros relacionados

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
por: Poyntz, H, et al.
Publicado em: (2014)

Measuring exposure to non-tuberculous mycobacteria: defining and testing novel antigens
por: Checkley, A, et al.
Publicado em: (2012)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
por: Poyntz, H, et al.
Publicado em: (2011)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
por: Griffiths, K, et al.
Publicado em: (2013)

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.
por: Checkley, A, et al.
Publicado em: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
por: Marsay, L, et al.
Publicado em: (2013)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
por: Griffiths, K, et al.
Publicado em: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
por: Marsay, L, et al.
Publicado em: (2013)

Tuberculosis vaccines: Progress and challenges
por: Checkley, A, et al.
Publicado em: (2011)

Genomic and phenotypic characterization of Mycobacterium tuberculosis’ closest-related non-tuberculous mycobacteria
por: Camille Sous, et al.
Publicado em: (2024-06-01)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
por: Stylianou, E, et al.
Publicado em: (2015)

Tuberculosis vaccines: progress and challenges.
por: Checkley, A, et al.
Publicado em: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
por: Poyntz, HC
Publicado em: (2012)

The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.
por: Burl, S, et al.
Publicado em: (2010)

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection
por: Stylianou, E, et al.
Publicado em: (2011)

Facial cutaneous tuberculosis infected by non-tuberculous mycobacteria
por: Xu Zhang, et al.
Publicado em: (2024-10-01)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
por: Williams, A, et al.
Publicado em: (2005)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
por: Minassian, A, et al.
Publicado em: (2011)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, I, et al.
Publicado em: (2022)

Analysis of non-tuberculous mycobacteria types in high tuberculosis endemic areas
por: Na-na Li, et al.
Publicado em: (2025-02-01)

Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon
por: Valerie Flore Donkeng Donfack, et al.
Publicado em: (2024-03-01)

Culture and Detection of Mycobacterium tuberculosis (MTB) and Mycobacterium bovis (BCG)
por: Ran Chen
Publicado em: (2012-01-01)

Vaccination against tuberculosis: how can we better BCG?
por: Pitt, J, et al.
Publicado em: (2013)

Vaccination against tuberculosis: How can we better BCG?
por: Pitt, J, et al.
Publicado em: (2013)

Revaccination with BCG: does it work?
por: McShane, H
Publicado em: (2024)

Understanding BCG is the key to improving it.
por: McShane, H
Publicado em: (2013)

Pulmonary non-tuberculous mycobacteria and Mycobacterium tuberculosis complex co-infection: A pragmatic approach to its diagnosis and management in South Africa
por: C Opperman, et al.
Publicado em: (2024-09-01)

Rapid and accurate identification and differentiation of Mycobacterium tuberculosis and non-tuberculous mycobacteria using PCR kits available in a high-burden setting
por: Bernardo Castro-Rodriguez, et al.
Publicado em: (2024-04-01)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
por: Vordermeier, H, et al.
Publicado em: (2009)

DETECTION OF TUBERCULOUS MYCOBACTERIA IN THE BLOOD OF PATIENTS WHEN SUSPECTING TUBERCULOUS SEPSIS
por: V. N. Zimina, et al.
Publicado em: (2016-08-01)

Modern Methods of Identification of Non-Tuberculous Mycobacteria
por: G. N. Genatullina, et al.
Publicado em: (2025-02-01)

Spoligotyping of tuberculous mycobacteria isolated from humans and cattle
por: N. I. Khаmmаdov, et al.
Publicado em: (2020-04-01)

DETECTION AND DIFFERENTIATION OF NON-TUBERCULOUS MYCOBACTERIA AND M. TUBERCULOSIS COMPLEX BY REAL TIME PCR
por: V. V. Ustinova, et al.
Publicado em: (2016-09-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
por: Harris, SA, et al.
Publicado em: (2014)

Impact of Multiple Drug Resistant Tuberculous Mycobacteria on the Outcomes of Lung Resection for Fibrous Cavernous Tuberculosis
por: D. E. Omelchuk, et al.
Publicado em: (2023-03-01)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
por: Vordermeier, H, et al.
Publicado em: (2011)

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
por: Fine, P, et al.
Publicado em: (1996)

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
por: Satti, I, et al.
Publicado em: (2024)

Editorial commentary: Understanding BCG is the key to improving it
por: McShane, H
Publicado em: (2014)

Genomic insights into the plasmidome of non-tuberculous mycobacteria
por: Margo Diricks, et al.
Publicado em: (2025-03-01)